EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular Breast Imaging in the Screening Setting

Katherine A Smith, Katie N Hunt, Gaiane M Rauch, Amy M Fowler iD

Journal of Breast Imaging · 2023

DOI: 10.1093/jbi/wbad011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Breast Imaging, 2023. Verfasst von Katherine A Smith und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Department of Radiology, Rochester, MN, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: NCI NIH HHS, University of Wisconsin Carbone Cancer Center Support, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of breast cancer through screening mammography saves lives. However, the sensitivity of mammography for breast cancer detection is reduced in women with dense breast tissue. Imaging modalities for supplemental breast cancer screening include MRI, whole breast US, contrast-enhanced mammography, and molecular breast imaging (MBI). Molecular breast imaging with 99mTc-sestamibi is a functional imaging test to identify metabolically active areas in the breast with positioning analogous to mammography. Since 2011, there have been six large, published studies of screening MBI as a supplement to mammography involving over 6000 women from four different institutions. A multicenter, prospective clinical trial of 3000 women comparing breast cancer detection using screening digital breast tomosynthesis alone or in combination with MBI recently completed enrollment. This review focuses on the current evidence of MBI use for supplemental breast cancer screening, the strengths and limitations of MBI, and recent technological advances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansMammographyBreast DensityProspective StudiesEarly Detection of CancerMulticenter Studies as Topic

Stichwörter der Autor:innen

99mTc-sestamibibreast cancer screeningbreast densitybreast-specific gamma imagingmolecular breast imaging

Autor:innen und Institutionen

  • Mayo Clinic, Department of Radiology, Rochester, MN, USA.
  • The University of Texas MD Anderson Cancer Center, Department of Breast Imaging, Houston, TX, USA.
  • The University of Texas MD Anderson Cancer Center, Department of Abdominal Imaging, Houston, TX, USA.
  • University of Wisconsin School of Medicine and Public Health, Department of Radiology, Madison, WI, USA.
  • University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
  • University of Wisconsin School of Medicine and Public Health, Department of Medical Physics, Madison, WI, USA.

ORCID-Profile: Amy M Fowler

Förderung

  • NCI NIH HHS
  • University of Wisconsin Carbone Cancer Center Support
  • National Institutes of Health
  • Department of Radiology
  • University of Wisconsin School of Medicine and Public Health

Zitieren

APA

Smith, K. A., Hunt, K. N., Rauch, G. M., & Fowler, A. M. (2023). Molecular Breast Imaging in the Screening Setting. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbad011

Vancouver

Smith KA, Hunt KN, Rauch GM, Fowler AM. Molecular Breast Imaging in the Screening Setting. Journal of Breast Imaging. 2023. doi:10.1093/jbi/wbad011

BibTeX
@article{Smith2023,
  author = {Smith, Katherine A and Hunt, Katie N and Rauch, Gaiane M and Fowler, Amy M},
  title = {Molecular Breast Imaging in the Screening Setting},
  journal = {Journal of Breast Imaging},
  year = {2023},
  doi = {10.1093/jbi/wbad011}
}
Kostenlos starten →